Evaluation of β1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer-Reference-Cited by-同舟云学术

Evaluation of β1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer

Published:2002-09 Issue:3 Volume:187 Page:575-580
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Odunsi Kunle,Ghamande Sharad,Chandrasekaran E.V.,Ta Alyssa,Moysich Kirsten B.,Driscoll Deborah,Matta Khushi,Lele Shashikant

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference25 articles.

1. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer;Bast;N Engl J Med,1983

2. Predictive value of CA-125 antigen levels in second look procedures for ovarian cancer;Niloff;Am J Obstet Gynecol,1985

3. CA-125 serum levels correlated with second-look operations among ovarian cancer patients;Berek;Obstet Gynecol,1986

4. Does serum CA-125 level prior to second look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?;Patsner;Gynecol Oncol,1990

5. Second look laparotomy;Barter,1993

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central Role of β-1,4-GalT-V in Cancer Signaling, Inflammation, and Other Disease-Centric Pathways;International Journal of Molecular Sciences;2023-12-29

2. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer;Journal of Ovarian Research;2023-01-07

3. Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer;BMC Cancer;2021-03-04

4. Glycosylation markers in cancer;Advances in Clinical Chemistry;2019

5. Selective inhibition of glycosyltransferases by bivalent imidazolium salts;Bioorganic & Medicinal Chemistry;2013-03